Johnson & Johnson (JNJ)
147.90
+2.16
(+1.48%)
USD |
NYSE |
Apr 19, 16:00
147.75
-0.15
(-0.10%)
After-Hours: 20:00
Johnson & Johnson Total Return Level: 468.00 for April 18, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 18, 2024 | 468.00 |
April 17, 2024 | 464.88 |
April 16, 2024 | 463.86 |
April 15, 2024 | 473.94 |
April 12, 2024 | 473.71 |
April 11, 2024 | 477.79 |
April 10, 2024 | 482.32 |
April 09, 2024 | 489.03 |
April 08, 2024 | 486.78 |
April 05, 2024 | 489.35 |
April 04, 2024 | 489.71 |
April 03, 2024 | 495.36 |
April 02, 2024 | 506.50 |
April 01, 2024 | 506.66 |
March 28, 2024 | 507.98 |
March 27, 2024 | 507.24 |
March 26, 2024 | 500.21 |
March 25, 2024 | 498.44 |
March 22, 2024 | 498.47 |
March 21, 2024 | 500.14 |
March 20, 2024 | 500.17 |
March 19, 2024 | 501.62 |
March 18, 2024 | 503.38 |
March 15, 2024 | 507.94 |
March 14, 2024 | 511.25 |
Date | Value |
---|---|
March 13, 2024 | 517.32 |
March 12, 2024 | 522.59 |
March 11, 2024 | 517.74 |
March 08, 2024 | 512.25 |
March 07, 2024 | 510.16 |
March 06, 2024 | 511.67 |
March 05, 2024 | 513.69 |
March 04, 2024 | 513.28 |
March 01, 2024 | 520.60 |
February 29, 2024 | 518.22 |
February 28, 2024 | 518.77 |
February 27, 2024 | 516.94 |
February 26, 2024 | 516.33 |
February 23, 2024 | 519.70 |
February 22, 2024 | 515.23 |
February 21, 2024 | 509.55 |
February 20, 2024 | 506.92 |
February 16, 2024 | 502.71 |
February 15, 2024 | 503.28 |
February 14, 2024 | 496.34 |
February 13, 2024 | 498.66 |
February 12, 2024 | 503.06 |
February 09, 2024 | 499.59 |
February 08, 2024 | 498.44 |
February 07, 2024 | 503.48 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
320.16
Minimum
Mar 23 2020
564.45
Maximum
Apr 25 2022
472.67
Average
489.75
Median
Total Return Level Benchmarks
Amgen Inc | 365.28 |
Gilead Sciences Inc | 89.96 |
Eli Lilly and Co | 2147.17 |
Merck & Co Inc | 420.72 |
Shockwave Medical Inc | 327.25 |